Back to Candriam S.C.A. Candriam S.C.A.

EWTXEWTX
16 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in EDGEWISE THERAPEUTICS INC

Candriam S.C.A. previously held 0 shares of EWTX (EDGEWISE THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1.9M

Total Shares Change

-190,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$40.63
0
2026-Q1
Decreased
447,416
-10.7%
$14.1M0.1%$28.81
0
2025-Q4
Increased
501,214
+126.6%
$12.4M0.1%$24.54
45
2025-Q3
Decreased
221,159
-1.3%
$3.6M0.0%$15.75
0
2025-Q2
Decreased
223,990
-0.8%
$2.9M0.0%$13.17
0
2025-Q1
Decreased
225,796
-11.1%
$5M0.0%$23.27
0
2024-Q4
Decreased
253,965
-13.8%
$6.8M0.0%$27.06
0
2024-Q3
Decreased
294,624
-10.4%
$7.9M0.0%$26.09
0
2024-Q2
Unchanged
329,000
0.0%
$5.9M0.0%$18.01
0
2024-Q1
Increased
329,000
+6.8%
$6M0.0%$18.24
29
2023-Q4
Increased
308,000
+3.4%
$3.4M0.0%$10.94
27
2023-Q3
Unchanged
298,000
0.0%
$1.7M0.0%$5.73
0
2023-Q2
Unchanged
298,000
0.0%
$2.3M0.0%$7.53
0
2023-Q1
Unchanged
298,000
0.0%
$1.8M0.0%$6.66
0
2022-Q4
Increased
298,000
+56.8%
$2.7M0.0%$8.94
37
2022-Q3
New
190,000
-
$1.9M0.0%$9.60
36

Other major holders of EWTX: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used